Home > OJI>
Biography

Dr. Koon Ho Chan

University of Hong Kong, (Hong Kong) China


Email: koonho@hku.hk


Qualifications

2009-2012 Ph.D., University of Hong Kong, LKS Faculty of Medicine

2005-2007 MD, University of Hong Kong, LKS Faculty of Medicine

1987-1992 MBBS, University of Hong Kong, Faculty of Medicine


Publications (Selected)

Books and Book Chapters

  1. Chan KH. LAP Lambert Academic Publishing AG & Co. KG. Autoantibodies in Neurological Disorders: Neuronal and Muscle Autoantibodies in Paraneoplastic Neurological Disorders and Autoimmune Myasthenia Gravis, 2010.
  2. Chan KH. Paraneoplastic neurological disorders. In Kornberg A, ed. Bringing consensus to the use of IVIG in neurology. Expert consensus statements on the use of IVIG IN NEUROLOGY. The Asia-Pacific IVIG Advisory Board.1st Edition. 2004: P63-67.
  3. Ho SL, Cheung RTF, Mak W, Chan KH. Neurology long cases. In Lau CP, ed. Problem-based medical case management. Hong Kong: Hong Kong University Press, 2005: P177-191.
  4. Ho SL, Cheung RTF, Mak W, Chan KH. Neurology short cases. In Lau CP, ed. Problem-based medical case management. Hong Kong: Hong Kong University Press, 2005: P155-176.
  5. Chan KH. Paraneoplastic Neurological Disorders. In Kornberg A, ed. Bringing consensus to the use of IVIG in neurology. Expert consensus statements on the use of IVIG in Neurology. The Asia-Pacific IVIG Advisory Board. 2nd Edition. 2008: P90-96.
  6. Chan KH. Acute Disseminated Encephalomyelitis. In Kornberg A, ed. Bringing consensus to the use of IVIG in neurology. Expert consensus statements on the use of IVIG in Neurology. The Asia-Pacific IVIG Advisory Board. 2nd Edition. 2008: P112-115.
  7. Chan KH. Mutliple Sclerosis. In Kornberg A, ed. Bringing consensus to the use of IVIG in neurology. Expert consensus statements on the use of IVIG in Neurology. The Asia-Pacific IVIG Advisory Board. 2nd Edition. 2008: P116-123.
  8. Chan KH. Neuromyelitis Optica. In Kornberg A, ed. Bringing consensus to the use of IVIG in neurology. Expert consensus statements on the use of IVIG in Neurology. The Asia-Pacific IVIG Advisory Board. 2nd Edition. 2008: P124-127.

Journals

  1. Oral Presentation “Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: recommendation from a South-East Asian regional special interest group on myasthenia gravis”, at the 19th World Congress of Neurology, 2009.
  2. Poster Presentation “Chronic Inflammatory Demyelinating Polyradiculoneuropathy With And Without Diabetes Mellitus”, at the 19th Meeting of the European Neurological Society, Milan. Journal of Neurology, 2009.
  3. Poster presentation “Synergistic role of neuronal uncoupling protein homologues, UCP4 and UCP5, in neuroprotection against mitochondrial dysfunction in Parkinson’s disease”, at the 9th International Alzheimer's Conference / Parkinson's Conference, Prague, 2009.
  4. Poster presentation “Characterization of the promoter region of human neuronal uncoupling protein-4 (UCP4) and its neuroprotective role in Parkinson’s disease” at the 9th International Alzheimer's Conference / Parkinson's Conference, Prague, 2009.
  5. Oral presentation “Aquaporin-4 expression by thymoma of myasthenia gravis patients”, 20th Meeting of the European Neurological Society, Berlin, 2010.
  6. Poster presentation “Clinical Outcome of Hong Kong Chinese Relapsing Remitting Multiple Sclerosis”, at the 20th Meeting of European Neurological Society, Berlin, 2010.
  7. Poster presentation “Thymomatous myasthenia gravis among Hong Kong Chinese”, at the 20th Meeting of the European Neurological Society”, Berlin, 2010.
  8. Oral presentation titled “Aquaporin-4 autoantibodies from neuromyelitis optica patients induce aquaporin-4 loss without myelitis in mouse” in American Academy of Neurology Annual Meeting, April 2011, Hawaii.
  9. Attendance at the Fourth Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2011, Singapore.
  10. Attendance at the Fifth Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2012, Beijing.
  11. Attendance at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2012, Lyon.
  12. Attendance at the 7th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2014, Taipei.